Please assess the completion status of the following clinical trial:

Trial Title: Child and Adolescent Anxiety Disorders (CAMS)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for separation anxiety disorder, social phobia, or generalized anxiety disorder~Exclusion Criteria:~* Major neurological disorder or medical illness that would interfere with participation in the study

- Gender: ALL
- Minimum Age: 7 Years
- Maximum Age: 17 Years
- Healthy Volunteers: t

Study Arms:
- Sertraline (Type: ACTIVE_COMPARATOR): Participants received sertraline for 12 weeks.
- CBT (Type: ACTIVE_COMPARATOR): Participants received cognitive behavioral therapy for 12 weeks
- SRT + CBT (Type: ACTIVE_COMPARATOR): Participants received both sertraline and CBT for 12 weeks.
- Placebo (Type: PLACEBO_COMPARATOR): Participants received a placebo pill for 12 weeks.

Based on this trial design, predict the completion outcome and termination type (if applicable).